Stockscreener 앱 받기
17.83
0.73%
0.13
전일 마감가:
$17.70
열려 있는:
$17.72
하루 거래량:
285.48K
Relative Volume:
0.44
시가총액:
$1.90B
수익:
순이익/손실:
주가수익비율:
-
EPS:
-
순현금흐름:
1주 성능:
+0.88%
1개월 성능:
-30.22%
6개월 성능:
-30.22%
1년 성능:
-30.22%
1일 변동 폭
$0.00
$0.00
1주일 범위
$17.06
$18.82
52주 변동 폭
$16.07
$25.55
ADARx Pharmaceuticals, Inc. Common Stock Stock (ADRX) Company Profile
Compare ADRX vs VRTX, MRNA, REGN, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADRX
ADARx Pharmaceuticals, Inc. Common Stock
|
17.83 | 1.90B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
498.50 | 126.35B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
226.30 | 90.35B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
778.36 | 80.14B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
818.30 | 51.46B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
193.52 | 41.48B | 742.00K | -1.37B | -1.07B | -7.0731 |
ADARx Pharmaceuticals, Inc. Common Stock 주식(ADRX)의 최신 뉴스
Simeon George Discloses Investment at ADARx Pharmaceuticals with 9.3% Stake - TradingView
ADRX News & Events - Intellectia AI
OrbiMed Advisors Discloses Investment at ADARx Pharmaceuticals with 14.0% Stake - TradingView
Upcoming & Recent IPO'sIPOs Calendar - ca.finance.yahoo.com
ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering - FinancialContent
Form 4 ADARx Pharmaceuticals For: 30 September By Investing.com - Investing.com South Africa
ADARx Pharmaceuticals Director Reports Preferred Stock Conversions and IPO Share Purchase - Kalkine Media
At $17 a share, OrbiMed Israel Partners II buys 61,516 IPO shares in ADARx Pharmaceuticals (ADRX). - Stock Titan
Options on 170,692 shares at $17 each go to ADARx Pharmaceuticals (ADRX) chief scientific officer. - Stock Titan
ADARx Raises $446.3 Million in IPO Priced at $17.00 Per Share - Minichart
Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering - Legal Desire
ADARx Pharmaceuticals Shares Jump On Nasdaq Debut - Yahoo Finance
Another top IPO: Adarx’s $446M to advance clinical siRNA assets - BioWorld News
Adarx Pharmaceuticals allocates 55% of IPO to 10 investors By Investing.com - Investing.com
Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering - Latham & Watkins LLP
Adarx Pharmaceuticals allocates 55% of IPO to 10 investors By Investing.com - Investing.com
ADARx Pharmaceuticals, Inc. Common Stock (ADRX) Income StatementYahoo Finance - Yahoo! Finance Canada
ADARx Pharmaceuticals Prices Upsized $446.3 Million Initial Public Offering - Yahoo Finance
ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public - BioSpace
Form S-1 ADARx Pharmaceuticals For: 25 September By Investing.com - Investing.com UK
Adarx Pharmaceuticals IPO opens at $22.10, 30% above pricing - scanx.trade
Articles from ADARx Pharmaceuticals Inc. - FinancialContent
IPO calendar for: - Yahoo Finance Singapore
IPO calendar for: - Yahoo Finance Singapore
ADARx Pharmaceuticals prices $446.3M IPO at $17 per share - Investing.com
ADARx Pharmaceuticals prices upsized IPO at $17 per share - Investing.com
ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering - Yahoo Finance
Total common shares outstanding of ADARx Pharmaceuticals, Inc. – NASDAQ:ADRX - tradingview.com
Diluted net income available to common stockholders of ADARx Pharmaceuticals Inc. – NASDAQ:ADRX - tradingview.com
ADARx Pharmaceuticals (ADRX): ADARx Sets Terms, Targets Up to $372m in IPO, AbbVie Alongside - Smartkarma
ADARx Pharmaceuticals Plans IPO of 21.9M Shares at $15-$17 Each - Yahoo Finance
ADARx Pharmaceuticals Seeks IPO On Strong Collaboration Deal With AbbVie (Pending:ADRX) - Seeking Alpha
ADARx Pharmaceuticals, Inc. Common Stock (ADRX) 재무 분석
ADARx Pharmaceuticals, Inc. Common Stock (ADRX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
ADARx Pharmaceuticals, Inc. Common Stock 주식 (ADRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| George Simeon | Director |
Sep 28 '26 |
Buy |
17.00 |
1,600,000 |
27,200,000 |
5,554,094 |
| GORDON CARL L | Director |
Sep 28 '26 |
Buy |
17.00 |
950,000 |
16,150,000 |
14,325,529 |
| ORBIMED ADVISORS LLC | Director |
Sep 28 '26 |
Buy |
17.00 |
950,000 |
16,150,000 |
14,325,529 |
| SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner |
Sep 28 '26 |
Buy |
17.00 |
1,600,000 |
27,200,000 |
5,554,094 |
1.20%
0.19%
자본화:
|
볼륨(24시간):